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Slllnmary 
A procedure has been developed to isolate dendritic cells to a high degree of purity from fresh 
blood. Prior enrichment methods have relied upon an initial 1-2-d culture period. Purified fresh 
isolates lack the characteristic morphology, phenotype, and immunostimulatory  function of dendritic 
cells. The purified cells have the appearance of medium sized lymphocytes and express substantial 
levels of CD4, but lack the T  cell molecules CD3,  CDS,  and T  cell receptor.  When placed 
in culture, the cells mature in a manner resembling the previously described, cytokine-dependent 
maturation of epidermal dendritic cells (Langerhans cells). The ceils enlarge and exhibit many 
cell processes, express much higher levels of major histocompatibility complex class II and a 
panel of accessory molecules for T cell activation, and become potent stimulators of the mixed 
leukocyte reaction. Among the many changes during this maturation process are a fall in CD4 
and the appearance of high levels of B7/BB1, the costimulator for enhanced interleukin 2 production 
in T cells. These changes are not associated with cell proliferation, but are dependent upon the 
addition of monocyte-conditioned medium. We suggest that the freshly isolated CD4-positive 
blood dendritic cells are recent migrants from the bone marrow, and that subsequent maturation 
of the lineage occurs in tissues in situ upon appropriate exposure to cytokines. 
B 
lood is the most accessible tissue for the study of den- 
dritic cells (DCs) 1 in humans. As in other tissues and 
species, the isolated DCs have a group of distinctive features, 
many of which relate to the cell surface (1, 2). These include 
an unusual cell shape and motility, a distinct repertoire of 
surface molecules such as abundant MHC products and adhe- 
sion/costimulatory molecules, and strong APC function in 
T cell-dependent immunity. Prior methods for isolating DCs 
from blood began with a 1-2-d culture period of T-depleted 
blood mononuclear cells. During this time, dendritic cells 
acquired a low buoyant density (3) and little or no adherence 
to plastic (4), features that aided their separation from other 
non-T cells. 
A preliminary report of this work has been presented in abstract form 
at the Second  International  Symposium  on Dendritic Cells  in Fundamental 
and Clinical  Immundogy, Amsterdam, the Netherlands,  June 21-25,1992. 
I Abbreviation used in this  paper: DC, dendritic cell. 
Cells with the typical morphology of DCs are not readily 
recognized in fresh blood, a fact emphasized by Thomas et 
al. (5). Moreover, it is known that certain populations of freshly 
isolated DCs exist in a less immunostimulatory or immature 
state. The best studied example is the epidermal Langerhans 
cell, which undergoes a series of changes when placed into 
culture (6-13).  The cells become larger and more dendritic 
in shape, synthesize large amounts of MHC products and 
accessory molecules, and develop strong T cell binding and 
stimulatory function. Analogous changes have been observed 
in DCs cultured from spleen (14) and lung (15). Maturation 
in each case is driven by cytokines, particularly GM-CSF (7, 
14,  15). 
Using recently described cytofluorographic criteria for iden- 
tifying DCs (1), we set out to isolate these APCs from fresh 
blood. The topic is of further interest because of recent findings 
that DCs are able to carry HIV-1 to antigen-responsive T 
cells and induce extensive lymphocyte destruction (16). Here, 
we describe a method for purifying DCs from fresh blood. 
We find that the cells express high levels of CD4 and are 
immunologically  immature in several respects. When placed 
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surface antigen phenotype, and immunostimulatory  function, 
and these events require a monocyte-conditioned medium. 
Materials and Methods 
Culture Medium.  H10 contains 10% heat-inactivated human 
serum (6102; Biocell, Rancho Dominquez, CA), 20 tLg/ml gen- 
tamicin (Gibco Laboratories,  Grand Island, NY), and 10 mM Hepes 
in RPMI 1640 (Gibco Laboratories). 
DC Purification  from Fresh Blood,  Buffy  coats from units of  blood 
were purchased from the New York Blood Center. Mononudear 
ceils were isolated  by flotation on Ficoll-Hypaque  (Pharmacia, Upp- 
sala, Sweden). T cells were depleted by rosetting with neuramini- 
dase (Calbiochem-Behring Corp.,  La Jolla,  CA)-treated  sheep 
erythrocytes (Cocalico, Reamstown, PA). For convenience, when 
blood was obtained late in the day, the T-depleted mononuclear 
cells (Er-) were left overnight on ice. This did not change the 
results. Monocytes were removed from the Er- by adherence to 
human gamma globulin (Calbiochem-Behring  Corp.)-coated petri 
dishes  (Falcon Labware, Oxnard,  CA)  (3). The  remaining 
Er-FcR- cells were mixed with a cocktail of mAbs against CD3 
(leu 4; Becton Dickinson & Co., Mountain View, CA), CD21 
(HB135; American Type  Culture Collection, Rockville, MD), and 
CD16 (3G8; kind gift ofJ. Unkeless [17]) to labd T, B, and NK 
cells, respectively.  After a 0.5-h incubation on ice, unbound mAbs 
were washed away with Ca  2~- and Mg2+-free medium (lx  Hanks 
[Gibco Laboratories] +  1% BSA +  1 mM EDTA), and the cells 
were panned by adherence  to goat anti-mouse IgG (Cappel Labora- 
tories, West Chester, PA)-coated petri dishes. Nonadherent cells 
were stained with PE-labeled mAbs to monocytes, B cells, and NK 
cells (CD14, CD19, and CD56, respectively)  and fluorescein-labeled 
anti-HLA-DR (Becton Dickinson & Co.), and washed in Ca  2+- 
flee medium. Cells that were PE cocktail negative  but DR positive 
were then purified on a FACStar Plus  |  cell sorter (Becton Dick- 
inson & Co.). The FITC-anti-HLA-DR did not inhibit DC func- 
tion under the conditions used here (data not shown). For pheno- 
typing studies with indirect antibodies (below), we omitted the 
FITC-anti-HLA-DR. 
DC Purification from Cultured Blood.  Day 2 DCs were prepared 
by culturing the Er-  fraction for 36 h in H10 on tissue culture 
dishes (Falcon Labware) before continuing with the purification 
procedure outlined above. Alternatively, a prior method (1) using 
metrizamide density gradients was used. 
Techniques Used to Decrease Aggregates.  To obtain high yields 
using a cell sorter, aggregation in the presorted fraction must be 
minimized. During the last steps of the purification, it was critical 
to wash cells in Ca  2+- and Mg2§  medium. Also, if SRBCs 
persisted in the Er-  fraction, we used NH4CI to lyse the sheep 
ceils. This can lead to some death and aggregation, but 5/xg/ml 
DNAase (Boehringer Mannheim Biochemicals, Indianapolis, IN) 
disrupted many of the aggregates. 
Viability Studies.  Purified  day 0 DCs were cultured in H10 sup- 
plemented with various purified cytokines or conditioned media. 
DCs were plated at 106/ml, 200/xl  per flat-bottomed microtest 
well in 96-well plates (Coming, Coming, NY). After 36 h of cul- 
ture, cells  were collected  and counted by trypan blue (Sigma  Chem- 
ical Co., St. Louis, MO) exclusion.  Monocyte-conditioned  medium 
was prepared by culturing plastic-, or human gamma globulin-, 
adherent cells (monocytes) for 24 h and harvesting the culture su- 
pernatant.  Alternatively,  T  cell-depleted  (Er-)-conditioned 
medium was prepared by culturing these cells in H10 for 24 h at 
5  x  l@/ml.  Conditioned  media were  stored in  aliquots at 
-20~  Two purified cytokines  were tested: GM-CSF (10  s U/rag; 
Kirin, Maebashi, Japan) and TNF-a (2  x  107 U/rag; Genzyme, 
Cambridge, MA). Lymphocult  |  (811020; Biotest Diagnostic, Den- 
ville, NJ) is a supernatant  from PHA-stimulated  blood mononuclear 
cells from which the PHA has been selectively  removed. 
Cytospin Preparations.  These were made in a cytocentrifuge 
(Shandon Southern  Instruments  Inc.,  Sewickley, PA), loading 
2  x  104 cells/slide. Slides were stored with desiccant at  -20~ 
before fixation in acetone and staining with anti-HLA-DK or anti- 
HLA-A,B,C (HB95; ATCC), followed  by biotin goat anti-mouse 
Ig (4753; Boehringer  Mannheim  Biochemicals),  avidin-biotin/horse- 
radish peroxidase (PK4000; Vector  Laboratories, Burlingame,  CA), 
and diaminobenzidine (04008; Polysciences, Warrington, PA). 
Phenotyping with mAbs.  A panel of mAbs was used to charac- 
terize day 0 DCs, day 2 DCs, and day 0 DCs cultured for 36 h 
in Er--conditioned  media (see Results and Table 1). When an in- 
direct immunolabeling method (mAb followed  by anti-mouse Ig) 
was needed as in Fig. 5, it was necessary  to modify the procedure 
shown in Fig. 1 so that the sorted DCs would not be labeled with 
anti-HLA-DR.  The cocktail of mAbs used for panning were PE 
labeled and included reagents to CD3, CD14, CD16, and CD19. 
The larger cocktail-negative cells were selected using a FACStar 
Plus |  (Becton Dickinson & Co.) cell sorter. Aliquots of the sorted 
cocktail-negative  cells were stained with primary mouse mAb fol- 
lowed by PE goat anti-mouse IgG. Cells were quenched with 100 
/~g/ml mouse IgG (015000003; Jackson, Westgrove,  PA) and then 
stained with FITC-anti-HLA-DR.  DR-positive cells, which ac- 
counted for >90% of sorted cells, were then analyzed for PE stain 
on a FACScan  |  (Becton Dickinson & Co.). 
Mixed Leukocyte Reactions.  DCs were irradiated with 1,500 rad 
of lS7Cs gamma radiation and added in graded doses to 2  x  10  s 
purified allogeneic  T cells in 96-well flat-bottomed microtest plates. 
Allogeneic  T cells were prepared by removing contaminating non-T 
cells in E-rosette-positive  populations by gamma globulin panning 
followed by panning with anti-MHC class II mAb. [3H]Thymi- 
dine incorporation was measured  at 120-132 h (6 Ci/mmol, 4 ~Ci/ 
ml final). 
~SIlIgs 
A prior study (1) established that flow cytometry was useful 
in identifying dendritic cells in cultured human blood, and 
in developing an enrichment method. The DCs were identified 
in terms of their large size, absence of critical markers of other 
cell types ("null" phenotype), and expression of MHC class 
II. The non-DCs in cultured blood comprise at least 99% 
of the cells and could be removed by successive depletion of 
T cells, monocytes, and both B and NK cells. This was ac- 
complished by E-rosetting, gamma globulin panning, and 
sedimentation on metrizamide columns. When we tried to 
repeat this method on fresh blood, we encountered a number 
of difficulties.  Notable among these,  we could not readily 
identify DCs that were typical in size and shape, nor could 
we use metrizamide columns to enrich "candidate" DCs, 
defining as candidates those cells that were negative for T, 
B, NK, and monocyte markers, but positive for HLA-DR. 
During the course of developing a method to purify DCs 
from fresh blood, we found that the cells expressed substan- 
tial levels of CD4, and only acquired the features of typical 
DCs after a period of maturation in culture. 
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Figure  1.  DC purification from fresh or cultured white blood cells. 
(Cocktail) Mixture  of  mAbs to non-DCs, e.g., to CD3, CD16, and CD21. 
(PE-cocktail) Mixture of PE-conjugated  mAbs to independent antigens, 
e.g., CD14, CD19, and CD56. 
Isolation Procedure to Prepare Fresh and Cultured DCs.  The 
procedure (Fig.  1) began by depleting T cells and monocytes 
using E-rosetting and adherence to gamma globulin-coated 
petri dishes, respectively. Then, panning and two-color cell 
sorting were used to deplete residual non-DCs. The panning 
step replaced the metrizamide flotation step of the prior pro- 
cedure, since fresh DCs do not have a low buoyant density 
(3).  The enrichment of candidate DCs was monitored by 
cytofluorography (Fig. 2). We looked for enrichment of cells 
that were HLA-DK positive but "null" i.e., lacking markers 
of other leukocyte lineages.  The candidate DCs in Fig. 2 are 
in the box that is PE cocktail negative and FITC-HLA-DR 
positive. These cells were not detectable in the T cell-enriched 
Er §  fraction and were just detectable (2-4%)  in the Er- 
fraction.  2-7%  of the  Er-FcR-  were DCs.  When  the 
Er- FcR- cells were coated with a group of mAbs to CD3, 
CD16,  and CD21  and panned on goat anti-mouse-coated 
petri dishes, the nomdherent cells were 9-27% candidate DCs. 
This percentage was sufficient to permit a final purification 
by two-color cell sorting, using an independent panel of PE- 
conjugated mAbs to label non-DCs (anti-CD14, 19, 56) and 
FITC-anti-HLA-DK. The sorted cells were 98% pure. Al- 
though smaller than day 2 DC, the sorted cells were slightly 
larger than resting lymphocytes (Fig.  3). 
Fresh DCs Require Monocyte-conditioned  Medium to Remain 
Viable and Develop a Characteristic Mo~hology.  The candi- 
date DCs that were freshly isolated on day 0 did not have 
the stellate shape of cultured DCs. When cultured in stan- 
dard H10 medium, most of the cells died within 36 h. How- 
ever, viability was maintained at higher levels with several 
conditioned media (Fig.  4).  Of the media tested, Er--  or 
monocyte-conditioned media supported viability the best. In- 
dividual cytokines were not very active (data not shown), 
although GM-CSF resulted in improved viability (>30%) 
over H10 alone. 
In cytospin preparations, the day 0 DCs had the appear- 
ance of medium-sized lymphocytes, lacked processes, and ex- 
pressed intermediate levels of HLA-DR (Fig. 5). During the 
first few hours of culture in Er-- or monocyte-conditioned 
media, the cells were round and dispersed, but by 12 h ag- 
gregates formed. After 36 h, cytoplasmic processes  or veils 
extended from the surfaces of the aggregates. When the cells 
were cultured in H10, some aggregates formed, but not all 
DCs entered the aggregates, in contrast to the uniform aggre- 
gation  of DCs  exposed to ER--conditioned  medium.  In 
H10, cytoplasmic processes did not develop to the same ex- 
tent as with the conditioned medium. After culture in Er-- 
or monocyte-conditioned medium for 36 h, the cells were 
larger, had many processes, and expressed high levels of HLA- 
DR, like day 2 DCs. Both class I and II MHC products were 
noted in a high concentration in the perinuclear region of 
the cultured DCs (Fig.  5). 
Fresh blood DCs did not appear to proliferate, since all 
nuclei contained a 2n (diploid) level of DNA with propidium 
iodide staining (data not shown). 
CD4 Levels on Fresh and Cultured DCs (Fig. 6).  On staining 
sorted day 0 and day 2 DCs, we were surprised to find that 
the former had relatively high levels of CD4. The levels were 
much higher than on plastic adherent monocytes (prepared 
by adhering fresh Er- cells to tissue culture dishes for 1-2 h) 
and approached the levels on CD4-positive T cells. Although 
DCs shared CD4 with T  cells,  there was no CD3,  TCK, 
or CD8  (below). Culturing day 0 DCs for 36 h  in Lym- 
phocult or 10% human serum (data not shown) resulted in 
a slight decrease in CD4 expression. However, if the cells 
were cultured in Er--  or monocyte-conditioned medium, 
CD4 expression was markedly decreased. 
Cell Surface Phenotype before and after Culture (Fig. 7 and 
Table I).  Fresh DCs lacked several markers that are typical 
of monocytes, B cells, and NK cells (Table 1). The MHC- 
related molecules (HLA-DK,-DQ,-DP, class I, and invariant 
chain) were expressed at moderate levels on day 0 and up- 
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Figure  2.  Monitoring the DC purification procedure. Two-color  staining  was performed on aliquots  of each call fraction. Dot plots of FITC-anti- 
HLA-DR vs. PE-cocktail  (CD3,  CD14,  CD19,  CD56) are shown. In this experiment, we panned  the Er-FcR-  with a cocktail  of mAbs toCD3, 
16,  and 21.  The percentage  of DCs (cocktail  negative,  but DR. positive)  are listed beside  the boxed  cells  (averages of four experiments).  Candidate 
DCs were never detected  in the Er + fraction,  but are always found in the Er-  fraction and greatly increase in frequency in the cocktail  nonadherent 
calls.  The double-negative  cells  seen in the cocktail  nonadherents  of this figure  and Fig.  3  are T  cells.  These cells  are not stained since we panned 
them with an unlabeled  anti-(CD3),  which prevented PE-anti-CD3 from binding. Labeling  the T  calls with a PE-labeled antibody is not necessary 
since  these  cells  are HLA-DR negative;  however,  the T  cells can be tagged with TCR-PE. 
regulated some 10-fold upon culture to the levels  found on 
DCs purified from cultured mononuclear cells.  Many adhe- 
sion and costimulatory molecules (B7/BB1, LFA-3 [CD58], 
ICAM-1  [CD54],  CD5,  and CD40) were also expressed  at 
higher levels after culture. B7/BB1, a costimulator molecule 
that enhances [L-2 production (18,  19), was not expressed 
on day 0 DCs. Fc'yRII (CD32) and Fc'yRI (CD64) were ex- 
pressed weakly on day 0 DCs but were absent after culture. 
Most fresh DCs, like naive T cells, were CD45RA positive, 
CD45RO negative, and IL-2R (CD25) negative. Upon cul- 
ture,  a more activated  phenotype developed,  including  ex- 
pression of CD25. 
Expression of certain molecules did not change with cul- 
ture. CDlla, CD18, CD29, CD43, CD45, and CD72 were 
all present, while CD70 was absent on all three kinds of DCs. 
In  general,  day  0  DCs  cultured  in  Er--conditioned 
medium  resembled prior day 2 isolates except for two an- 
tigens, CD45RA and CDllc. When purified DCs were cul- 
tured  in  conditioned  medium,  the  phenotype  remained 
CD45RA + and CD11c-,  whereas when DCs were purified 
after culture,  the phenotype was CD45RA-  and CDllc + . 
There was a small subset of fresh DCs that expressed CDllc, 
CD45RO,  and CD5. This phenotype was intermediate be- 
tween the majority of fresh  and cultured DCs and implies 
that there is an additional, more activated population of DCs 
circulating in the blood. A  small fraction of fresh DCs also 
expressed CD2 and CD7, but these antigens were not present 
on cultured DCs. 
Enhanced T Celt-stimulating Function after Maturation (Figs. 
8 and 9).  Fresh DCs were poor stimulators of the aUogeneic 
MLR, but after culture in conditioned medium,  the APCs 
had become as potent stimulators as day 2 DCs. In dose-re- 
sponse studies,  stimulatory activity increased 10-30-fold after 
culture. The MLRs induced by day 0 DCs were pulsed with 
[3H]TdR at several time points (120,  144,  and 156 h), in case 
a longer culture period was needed to detect T cell stimula- 
tion, but little (less than threefold) to no increase in prolifer- 
ation was  seen at these later  times  (data  not shown). 
Many studies have used fresh blood mononuclear cells to 
stimulate allogeneic T cells. Initially,  this appeared to conflict 
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Figure  3.  FACScan  |  analysis of presorted and sorted cells during  the 
isolation of fresh DCs. (~p left) Presorted cells stained with PE-cocktail 
and FITC-anti-HLA-DR.  The boxed cells represent the cells selected by 
the sorter. After sorting (top right),  98% of the ceils were within the box. 
On the bottom are PE-cocktail vs. forward scatter plots of presorted (left) 
and sorted  calls (right)  to demonstrate  that DCs have a slightly higher 
forward  scatter relative to  lymphocytes in the presort population. 
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Figure 4.  Viability of day 0 DCs after culturing  for 36 h in conditioned 
media or cytokine-supplemented media. (n) Number of experiments that 
were averaged to give the percent viability. The supplements were: Er-, 
50% Er--conditioned medium; monocyte, 50% monocyte-conditioned 
medium; Lymphocult, 30% Lymphocult; GM-CSF, 490 ng/ml; and GM- 
CSF  +  TNF-ot, 3 ng/ml. 
with our data,  where fresh DCs were poor stimulators  of 
foreign T cells, until we realized that other leukocytes could 
be providing cytokines that DCs needed for maturation into 
potent  stimulators.  We  wondered whether adding  Er-- 
conditioned medium directly to an allo-MLR would enhance 
the immunostimulatory  capacity of fresh DCs. We prepared 
highly enriched sorted populations, irradiated them, and added 
the APCs in graded doses to purified allogeneic T  cells in 
control medium or medium supplemented with 40% Er-- 
conditioned medium. The latter enhanced stimulatory ac- 
tivity almost  10-fold (Fig. 9). 
Discussion 
To study the induction of T cell-dependent immune re- 
sponses in several clinical contexts,  it would be of value to 
use human blood dendritic cells (20). DCs are potent APCs 
and capable of inducing primary immune responses in tissue 
culture and whole animal models (21). Blood has been one 
of the many tissues that has been used as a source of DCs 
Figure 5.  Cytospin  mor- 
phology of fresh (day 0) DCs and 
day 0  DCs  cultured for  36  h  in 
Er--conditioned  medium.  DCs 
were purified as in Fig.  1 except 
FITC-anti-HLA-DR  was  not 
added. DCs were sdect~ by sorting 
for PE-cocktail negatives. (A) Fresh 
DCs,  MHC  class II stain,  phase 
contrast; (B) fresh DCs, MHC class 
II stain,  brightfield  to  show  the 
brown  reaction  product  in  the 
cytoplasm; (C) fresh DCs, MHC 
class I  stain,  phase contrast;  (D) 
DCs  cultured  in  monocyte-con- 
ditioned medium, MHC  class II 
stain, phase contrast;  (E) cultured 
DCs, MHC class II, bright field; 
(F)  cultured DCs,  MHC  class I 
stain, phase contrast. Arrows point 
to  a  concentration of MHC  an- 
tigens in the perinudear areas  of the 
DCs. 
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Figure 6.  CD4 is expressed  by 
freshly isolated human DCs. DCs 
were  purified  as in Hg. I and stained 
with PE-anti-CD4 (mAb leu 3a) 
immediately  or after culture in ei- 
ther monocyte-conditioned  medium 
or Lymphocult  for 36 h. For com- 
parison, monocytes  (prepmxt  by ad- 
hering fresh Er-  for  1-2  h  on 
tissue culture dishes), T cells (Er + 
cells), and day 2 DCs are also stained 
with PE-anti-CD4.  The dotted  lines 
are isotype-matched  controls  and the 
solid lines are obtained with PE- 
anti-CD4. 
in humans, the others being tonsil (22),  skin (9), rheuma- 
toid synovial effusions (23-25), thymus (26),  gut (27),  and 
lung (28). In blood, as in other tissues, DCs are distinguished 
by strong MLR stimulatory activity and an absence of typ- 
ical monocyte and lymphocyte markers (1, 29,  30).  Subse- 
quent studies have used human blood to probe other aspects 
of DC function, including the expression of adhesion and 
costimulator molecules (31), the immunoselection of antigen- 
reactive T cells for cloning procedures (32, 33), and the pre- 
sentation of human pathogens and superantigens (33, 34). 
However in all prior work, a culture period of 1-2 d has been 
part  of the purification protocol.  We have worked out  a 
method for reliably enriching these APCs from fresh blood. 
The purified DCs prove to be immature in several respects 
and require supplementation with cytokines to develop fur- 
ther.  Our findings are discussed from several perspectives. 
The Purification Procedure.  To purify DCs we made sev- 
eral assumptions based on prior work. DCs would: (a) not 
rosette sheep erythrocytes (in contrast to T cells); (b) express 
little to no Fc receptors that bind to dishes coated with human 
Ig (in contrast to monocytes); (c) lack such differentiation 
antigens as CD3, CD14,  CD16,  CD19,  CD21,  and CD56 
(in contrast to other lineages); but (d) express detectable levels 
of MHC class II molecules. After depleting non-DCs on the 
basis of the criteria above, we still required a final purification 
step by FACS  |  Of considerable importance was the need 
for calcium-free media to prevent cell aggregation, and the 
use of cytofluorography to monitor DC enrichment and yields 
(Figs.  1 and 2). 
Thomas et al, (5) have also approached the study of DCs 
in fresh blood, but using different methods from ours. For 
example, they designed other approaches to deplete mono- 
cytes by emphasizing the selection of CD33+CD14 -  cells 
while we depleted monocytes by adhering them to gamma 
globulin-coated petri dishes. We have not had the opportu- 
nity to compare the two methods. However, the findings of 
Thomas et al. (5) are different from ours. In particular, the 
cytokine-dependent maturation process of fresh DCs did not 
seem to occur. Cytokines did not appear to be needed to main- 
tain viability; the development of potent MLR stimulatory 
function was not observed; and the marked upregulation of 
the B7/BB1 antigen, except on a minority of cells, was not 
evident. It is possible that CD33+CD14 -  populations are 
less enriched in DCs than the population described here. 
The  Maturation Phenomenon.  In  the  case  of DCs  in 
epidermis (6), and to some extent in spleen (14) and lung 
(15), there is information that the phenotype and function 
of freshly isolated DCs change markedly in culture.  This 
phenomenon is termed "maturation" because it occurs in the 
absence of cell proliferation and entails the development of 
strong T cell stimulatory function (6, 7), as well as such as- 
sociated features as expression and/or upregulation of adhe- 
sion and costimulatory molecules (9-13). When we tried to 
identify DCs in fresh blood, we found that the APCs were 
immature on several grounds: morphology (Fig.  5), i.e.,  an 
absence of cytoplasmic processes;  cell surface composition, 
i.e., relatively low levels of MHC products and accessory mol- 
ecules (Fig. 6); and function, i.e., weak stimulator), capacity 
in the allogeneic MLR (Fig. 8). The weak stimulatory func- 
tion of fresh DCs is consistent with their low expression of 
accessory molecules in contrast to day 2 DCs (31). GM-CSF, 
a monocyte product, by itself did not fully replace the func- 
tion of monocyte-conditioned medium. GM-CSF only par- 
tially improved viability, and many of the surviving cells still 
expressed CD4 (data not shown). The effects of GM-CSF 
on DCs from other tissues have been more marked (7). IL-6, 
another monocyte product, did not improve viability and did 
not enhance the effects of GM-CSF (data not shown). Fur- 
1072  Immature  Dendritic Cells in Fresh Blood Table  1.  Summary of the Cell Surface Phenotypes of Day 0 DCs, Day 2 DCs, and Day 0 DCs Cultured in T Cell-depleted 
Conditioned Medium 
Day 0 DC, 
Antigen  Source  Day 0 DC  cultured 2 d  Day 2 DC 
Monocytes 
CD14  ATCC (TIB 228) 
B cells 
CD19  AMAC 
CD20  Becton Dickinson & Co. 
NK cells 
CD56  Becton Dickinson & Co. 
T  cells 
CD2  Dako Corp. 
CD3  Becton Dickinson &  Co. 
CD4  " 
CD5  " 
CD7  Serotec 
CD8  Becton Dickinson &  Co. 
TCR  " 
MHC 
HLA-A,B,C  ATCC (HB95) 
HLA-DR  Becton Dickinson & Co. 
HLA-DP  PL-15  (gift  of Dr.  S.Y. 
Yang,  New York,  NY) 
HLA-DQ  ATCC, HB144 
Ii CD74  BU45 (40)  (gift of G. 
Johnson) 
Adhesins and costimulators 
CD54  84H10 (41) 
CD58  ATCC (HB205) 
B7/BB1  Becton Dickinson & Co. 
CD11a  ATCC (HB202) 
CD11b  Exalpha 
CD11c  Becton Dickinson & Co. 
CD18  IB4  (42) 
CD29  AIA5 (43) 
CD40  Biosource 
CD72  Serotec 
Activation 
CD45RA  Serotec 
CD45RO  UCHL-2 (44) 
CD25  Becton Dickinson &  Co. 
Receptors 
CD16  Becton Dickinson &  Co. 
CD32  AMAC 
CD64  ATCC (HB9469) 
Miscellaneous 
CDla  Coulter 
CD43  Becton Dickinson & Co. 
CD45  ATCC (HB196) 
CD70  Serotec 
Most  -,  few  +  -  - 
+  +  + 
Most  -,  few  +  +  Half  -,  half  +  +  Few  -,  most  +  + 
Most  -,  few  +  -  - 
+++  ++++  ++++ 
++  +++  +++ 
++  +++  +++ 
++  +++  +++ 
+  +  +  to  +  +  +  +  +  tO  +  +  + 
++  +++  ++ 
+  ++  ++ 
--  ++  + 
++  ++  ++ 
Most  -,  few  +  +  Most  -,  few  +  +  Few  -,  most  +  + 
++  ++  ++ 
++  ++  ++ 
+  to  +  ++  ++ 
+  +  + 
Few  -,  most  +  Few  -,  most  + 
Most  -,  few  +  Most  _+,  few  +  Few  -,  most  + 
--  +  + 
.4-  -  -- 
++  ++  ++ 
++  ++  ++ 
Each  +  corresponds to an increase in fluorescence intensity of one logarithm using the scale in Fig. 7. 
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Figure 7.  Cell surface phenotype of day 0 DCs, compared with day 2 DCs, and day 0 DCs cultured for 2 d in T cell-depleted conditioned medium. 
The antibodies are presented in groups, corresponding to MHC-related  antigens, costimulators and adhesins, T cell antigens, and activation antigens. 
The dotted lines are isotype-matched  nonreactive control mAbs.  Staining with anti-class ] and anti-class II mAbs of day 0 DCs cultured  2 d and 
day 2 DCs is offscale. 
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Figure 8.  The MLR stimulatory  capacity  of  day  0 and day 2 DCs, with 
and without prior culture of the APCs in conditioned medium from 
E-rosette-negative  mononuclear  cells. Graded  doses  of  irradiated  DCs were 
used to stimulate  2 x 10  s aUogeneic  T cells. Cells were pulsed  with [3H]- 
TdR for 12 h after 120 h of culture. 
120 
ioo  ? 
C3 
~<  80 
t  60 
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2O 
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Figure 9.  MLR stimulation  by day 0 DCs in the presence and absence 
of 40% Er--conditioned  medium added continuously  to the MLR cul- 
ture. Irradiated  DCs were added at graded doses to 2 x 10  s purified al- 
logeneic T cells as in Fig. 8. 
ther study will be required to identify the factors that mediate 
the phenomenon described here. Nevertheless,  our findings 
suggest that when APC function is evaluated in human blood, 
the stimulatory role of DCs is at least partly dependent upon 
cytokines being made by other cell types. Indeed, if Er- - or 
monocyte-conditioned medium is added to the MLR when 
the stimulator cells are fresh DCs, the response rises dramat- 
ically (Fig.  9). 
The Origin and Destination of DCs in Fresh Blood.  From 
the phenotyping experiments, there appeared  to be at least 
two populations of DCs in blood. The majority expressed 
the CD45RA+/RO -  markers.  We hypothesize these are 
immature DCs that have recently migrated from the bone 
marrow. A minor subpopulation expressed CD5, CDllc, and 
CD45RO.  These may represent a more mature population 
that had been exposed to cytokines after passage through other 
tissues. This is possible  since DCs have been shown to mi- 
grate from cardiac allografts through the blood to spleen in 
mouse (35). 
CD4 Expression by Human Blood DCs.  CD4 is expressed 
at low levels on human Langerhans cells (36) and on precursors 
in mouse marrow (37).  CD4 is also detected on DCs that 
grow out from precursors  in human umbilical cord blood 
in the presence  of GM-CSF and TNF-cx  (38). 
The expression  of CD4 that is described  here may cast a 
new light on the potential contribution of DCs to the patho- 
genesis of AIDS. Expression of CD4 does not necessarily in- 
dicate that DCs are readily infected with HIV, since the levels 
of proviral DNA that have been detected in cultured DCs 
from HIV-l-infected individuals in a single study corresponds 
to less than <1 in 1,000 DCs (39).  Prior work has shown 
that DCs, without being infected, can carry HIV to antigen- 
reactive T cells and lead to extensive T cell syncytium forma- 
tion and death (16). The presence of CD4 on DCs, which 
should allow high affinity  adsorption of HIV, dictates a reex- 
amination of these issues in fresh isolates. In contrast to prior 
work on cultured DCs, might the CD4-positive DCs in fresh 
blood be more susceptible  to infection with HIV-1 and/or 
be more efficient at trapping and carrying the virus to lym- 
phoid and nonlymphoid organs? 
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